you are here:

Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE044A01036 | SECTOR: Pharmaceuticals

BSE Live

Aug 10, 16:01
919.35 8.85 (0.97%)
Volume
AVERAGE VOLUME
5-Day
123,080
10-Day
286,612
30-Day
227,980
135,345
  • Prev. Close

    910.50

  • Open Price

    912.00

  • Bid Price (Qty.)

    919.35 (24)

  • Offer Price (Qty.)

    919.35 (76)

NSE Live

Aug 10, 15:58
919.70 9.30 (1.02%)
Volume
AVERAGE VOLUME
5-Day
3,017,600
10-Day
3,864,841
30-Day
2,940,760
3,077,870
  • Prev. Close

    910.40

  • Open Price

    913.20

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    919.70 (44)

Financials

2021 2020 2019 2018 2017
Half Yearly Results of Sun Pharmaceutical Industries (in Rs. Cr.) Mar '22 Sep '21 Mar '21 Sep '20 Mar '20  
Net Sales/Income from operations 7,758.88 7,808.44 6,485.05 6,085.88 5,671.24  
Other Operating Income 18.66 -- 62.61 169.67 178.39  
Total Income From Operations 7,777.54 7,808.44 6,547.66 6,255.55 5,849.63  
EXPENDITURE  
Consumption of Raw Materials 2,413.29 2,171.68 1,956.97 1,852.14 1,714.33  
Purchase of Traded Goods 563.16 685.44 672.08 527.55 622.00  
Increase/Decrease in Stocks -175.23 -7.95 -64.08 -150.76 -50.89  
Power & Fuel -- -- -- -- --  
Employees Cost 999.73 1,001.05 880.10 918.35 843.31  
Depreciation 709.38 640.57 298.65 288.16 286.84  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 2,320.36 2,706.93 1,676.10 1,598.76 1,786.53  
P/L Before Other 946.85 610.72 1,127.84 1,221.35 647.51  
Other Income 605.64 352.28 55.85 94.37 1,234.01  
P/L Before Int. 1,552.49 963.00 1,183.69 1,315.72 1,881.52  
Interest 176.66 211.44 174.66 82.32 236.29  
P/L Before Exceptional Items & Tax 1,375.83 751.56 1,009.03 1,233.40 1,645.23  
Exceptional Items -1,654.96 -165.57 -89.56 -- --  
P/L Before Tax -279.13 585.99 919.47 1,233.40 1,645.23  
Tax 491.65 -84.80 36.53 -23.36 20.62  
P/L After Tax from Ordinary Activities -770.78 670.79 882.94 1,256.76 1,624.61  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period -770.78 670.79 882.94 1,256.76 1,624.61  
Equity Share Capital 239.93 239.93 239.93 239.93 239.93  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS -3.21 2.80 3.68 5.24 6.77  
Diluted EPS -- 2.80 -- 5.24 --  
EPS After Extra Ordinary  
Basic EPS. -3.21 2.80 3.68 5.24 6.77  
Diluted EPS. -- 2.80 -- 5.24 --  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited